Baxter publishes annual corporate responsibility report, highlighting continued focus on creating lasting impact
Provides updates on Baxter’s 2030 CorporateResponsibility Commitment and Goals and reinforces the company’scommitment to transparent reporting
Baxter International Inc. (NYSE:BAX), a global medtech leader,today published its 2023 Corporate Responsibility Report. Theannual report showcases Baxter’s dedication to making a meaningfuldifference in global healthcare and reporting with transparency onthe environmental, social and governance topics most important toits stakeholders.
“Baxter employees across the globe are connected by our sharedcommitment to doing business the right way and continually drivinga positive impact for the patients, clinicians and communities weserve,” said José (Joe) E. Almeida, chair, president and chiefexecutive officer. “As we continue to focus on creating value forour stakeholders through our 2030 Corporate ResponsibilityCommitment and Goals, our approach will remain grounded in oursustainable business model and central to Baxter’s Mission to Saveand Sustain Lives.”
2023 Corporate Responsibility Highlights
Baxter’s 2023 Corporate Responsibility Report shares updates onthe company’s 2030 Corporate Responsibility Commitment and Goals,which support an overarching pledge to “Empower our Patients,”“Protect our Planet” and “Champion our People and Communities.” Keyaccomplishments highlighted in the report include:
- Invested more than $143 million since 2021 to supportunderserved communities through strategic partnerships anddonations.
- Announced a new partnership with UNICEF and a $2.5 millioncommitment through the Baxter International Foundation to improveclimate-smart access to safe drinking water and sanitation inwater-challenged regions of Egypt.
- Completed 150 energy conservation projects in 2023, which areestimated to reduce greenhouse gas (GHG) emissions by approximately21,100 metric tons carbon dioxide equivalent per year beginning in2024. This is nearly double the GHG emissions reduction achievedwith energy projects completed in 2022.1
- Continued to achieve top quartile workplace safety performance,as measured by total recordable incident rate.
Transparent Reporting on Priority Stakeholder Topics
Building on more than 30 years of reporting on environmental andsustainability performance, Baxter aims to consistently broaden andenhance its reporting on the corporate responsibility topics thatmatter to its stakeholders. In 2023, the company published itsinaugural report against the framework established by the TaskForce on Climate-related Financial Disclosures (TCFD) and nowreports against the TCFD framework annually in its CorporateResponsibility Report. Baxter is preparing to conduct a doublemateriality assessment to help evolve its approach to corporateresponsibility and ensure continued alignment with corporateresponsibility industry standards following the proposed separationof its Kidney Care business. This includes assessing any necessaryadjustments to Baxter’s 2030 Corporate Responsibility Goals toalign with the evolving interests and makeup of the company and itsstakeholders.
Baxter furthers its aspirations as a healthcare leader bycontinuing to advance efforts that demonstrate its commitment tooperating as a socially responsible and sustainable business and asan employer of choice. Learn more about Baxter’s corporateresponsibility commitment here.
About Baxter
Every day, millions of patients, caregivers and healthcareproviders rely on Baxter’s leading portfolio of diagnostic,critical care, kidney care, nutrition, hospital and surgicalproducts used across patient homes, hospitals, physician officesand other sites of care. For more than 90 years, we’ve beenoperating at the critical intersection where innovations that saveand sustain lives meet the healthcare providers who make it happen.With products, digital health solutions and therapies available inmore than 100 countries, Baxter’s employees worldwide are nowbuilding upon the company’s rich heritage of medical breakthroughsto advance the next generation of transformative healthcareinnovations. To learn more, visit www.baxter.com and follow us onX/Twitter, LinkedIn and Facebook.
This release includes forward-looking statements concerningBaxter’s 2030 Corporate Responsibility Commitment and Goals andother plans and initiatives described in the release. Thestatements are based on assumptions about many important factors,including the following, which could cause actual results to differmaterially from those in the forward-looking statements: thecompany’s ability to execute and complete strategic initiatives,asset dispositions and other transactions, including the proposedseparation of the company’s Kidney Care segment; the company’sability to execute on its capital allocation plans (including thosewith respect to Baxter’s 2023 Corporate Responsibility Commitmentand Goals); demand for and market acceptance for new and existingproducts; product development risks; inability to create additionalproduction capacity in a timely manner or the occurrence of othermanufacturing or supply difficulties (including as a result ofnatural disasters, public health crises and epidemics/pandemics,regulatory actions or otherwise); satisfaction of regulatory andother requirements; actions of regulatory bodies and othergovernmental authorities; product quality, manufacturing or supply,or patient safety issues; changes in law and regulations; and otherrisks identified in Baxter's most recent filing on Form 10-K andForm 10-Q and other SEC filings, all of which are available onBaxter's website. Baxter does not undertake to update itsforward-looking statements unless otherwise required by the federalsecurities laws.
Baxter is a registered trademark of Baxter InternationalInc.
1 Estimated greenhouse gas emissions reductions arecalculated for the full calendar year following projectimplementation
View sourceversion on businesswire.com: https://www.businesswire.com/news/home/20240710214310/en/
Media Contact
Andrea Johnson, (224) 948-5353
media@baxter.com
Investor Contact
Clare Trachtman, (224) 948-3020
Baxter (NYSE:BAX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Baxter (NYSE:BAX)
Historical Stock Chart
From Jul 2023 to Jul 2024
 | {{bbMessage.M_Alias}}{{bbMessage.MSG_Date}}{{bbMessage.HowLongAgo}}{{bbMessage.MSG_ID}}{{bbMessage.MSG_Subject}} |
Loading Messages....
Baxter International Inc News
Loading Messages....
`,data() {return {tabs: [] };},created() {this.tabs = this.$children;},methods: {selectTab(selectedTab) {this.tabs.forEach(tab => {tab.isActive = (tab.name == selectedTab.name);});}}});Vue.component('tab', {template: `
`,props: {name: { required: true },selected: { default: false}},data() {return {isActive: false};},computed: {href() {return '#' + this.name.toLowerCase().replace(/ /g, '-');}},mounted() {this.isActive = this.selected;}});Vue.component('newslist', {template: `
FEATURED
•{{ article.source }} • {{ article.date}} {{article.time}}
`,props: {source: { required: true },rawarticles: { required: true },limit: { default: 12 }},methods: {processData: function(articles){if(articles.length > this.limit){articles = articles.slice(0, this.limit);}this.articles = articles;this.loaded = true;Vue.nextTick(function(){});},stripRedudancies: function(articles){return _.uniqBy(articles, "headline");}},data() {return {loaded: false,articles: []};},mounted() {this.processData(this.rawarticles);}});new Vue({el: '#nw-news-widget',data: {loaded: false,availableTabs: {"Press Releases": [{"headline":"Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project","link":"https:\/\/ih.advfn.com\/common\/newswire\/ct\/MjIxMA==","timestamp":1721905200,"date":"Thu Jul 25, 2024 ","time":"7:00 AM (4 hours ago)","isPromoted":true},{"headline":"Form 8-K - Current report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/baxter-BAX\/stock-news\/94218452\/form-8-k-current-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1721335565,"date":"Thu Jul 18, 2024 ","time":"4:46 PM (7 days ago)","full_date":"July 18, 2024 4:46 PM","post_time":"July 18 2024","article_id":94218452,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Baxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors","short_text":"\nBaxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2024 financial results on Tuesday, August 6, 2024 at 7:30 a.m. Central...","one_line_short_text":"\nBaxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2024 financial results...","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/baxter-BAX\/stock-news\/94210634\/baxter-to-host-second-quarter-2024-financial-resul","source":"Business Wire","source_logo":"\/common\/images\/news-sources\/bw.png","tags":[],"timestamp":1721247300,"date":"Wed Jul 17, 2024 ","time":"4:15 PM (1 week ago)","full_date":"July 17, 2024 4:15 PM","post_time":"July 17 2024","article_id":94210634,"source_id":"bw","media_url":null,"press_release":true},{"headline":"Baxter Declares Quarterly Dividend","short_text":"\nBaxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend...","one_line_short_text":"\nBaxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend...","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/baxter-BAX\/stock-news\/94203559\/baxter-declares-quarterly-dividend","source":"Business Wire","source_logo":"\/common\/images\/news-sources\/bw.png","tags":[],"timestamp":1721162700,"date":"Tue Jul 16, 2024 ","time":"4:45 PM (1 week ago)","full_date":"July 16, 2024 4:45 PM","post_time":"July 16 2024","article_id":94203559,"source_id":"bw","media_url":null,"press_release":true},{"headline":"Baxter publishes annual corporate responsibility report, highlighting continued focus on creating lasting impact","short_text":"\nProvides updates on Baxter\u2019s 2030 Corporate Responsibility Commitment and Goals and reinforces the company\u2019s commitment to transparent reporting Baxter International Inc. (NYSE:BAX), a global...","one_line_short_text":"\nProvides updates on Baxter\u2019s 2030 Corporate Responsibility Commitment and Goals and reinforces the company\u2019s commitment to transparent reporting...","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/baxter-BAX\/stock-news\/94172380\/baxter-publishes-annual-corporate-responsibility-r","source":"Business Wire","source_logo":"\/common\/images\/news-sources\/bw.png","tags":[],"timestamp":1720614600,"date":"Wed Jul 10, 2024 ","time":"8:30 AM (2 weeks ago)","full_date":"July 10, 2024 8:30 AM","post_time":"July 10 2024","article_id":94172380,"source_id":"bw","media_url":null,"press_release":true},{"headline":"Paramount-Skydance $28B Merger, Boeing Agrees to Plead Guilty with $243.6M Fine, and More News","short_text":"\nParamount Global (NASDAQ:PARA) – Skydance Media and Paramount Global announced a merger, with Skydance acquiring National Amusem*nts for $2.4 billion before merging with Paramount. This...","one_line_short_text":"\nParamount Global (NASDAQ:PARA) – Skydance Media and Paramount Global announced a merger, with Skydance acquiring National Amusem*nts for...","link":"https:\/\/ih.advfn.com\/market-news\/article\/7862\/paramount-skydance-28b-merger-boeing-agrees-to-plead-guilty-with-243-6m-fine-and-more-news","source":"IH Market News","source_logo":"\/common\/images\/news-sources\/ihmarketnews.png","tags":[],"timestamp":1720435072,"date":"Mon Jul 08, 2024 ","time":"6:37 AM (2 weeks ago)","full_date":"July 8, 2024 6:37 AM","post_time":"July 08 2024","article_id":94157279,"source_id":"ihmarketnews","media_url":null,"press_release":true},{"headline":"Baxter to Present at Goldman Sachs 45th Annual Global Healthcare Conference","short_text":"\nBaxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024. Joel Grade, Baxter\u2019s chief...","one_line_short_text":"\nBaxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Goldman Sachs 45th Annual Global Healthcare Conference on...","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/baxter-BAX\/stock-news\/94000922\/baxter-to-present-at-goldman-sachs-45th-annual-glo","source":"Business Wire","source_logo":"\/common\/images\/news-sources\/bw.png","tags":[],"timestamp":1717704900,"date":"Thu Jun 06, 2024 ","time":"4:15 PM (2 months ago)","full_date":"June 6, 2024 4:15 PM","post_time":"June 06 2024","article_id":94000922,"source_id":"bw","media_url":null,"press_release":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/baxter-BAX\/stock-news\/93993002\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1717617831,"date":"Wed Jun 05, 2024 ","time":"4:03 PM (2 months ago)","full_date":"June 5, 2024 4:03 PM","post_time":"June 05 2024","article_id":93993002,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/baxter-BAX\/stock-news\/93992999\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1717617804,"date":"Wed Jun 05, 2024 ","time":"4:03 PM (2 months ago)","full_date":"June 5, 2024 4:03 PM","post_time":"June 05 2024","article_id":93992999,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form SD - Specialized disclosure report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/baxter-BAX\/stock-news\/93959010\/form-sd-specialized-disclosure-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1717157444,"date":"Fri May 31, 2024 ","time":"8:10 AM (2 months ago)","full_date":"May 31, 2024 8:10 AM","post_time":"May 31 2024","article_id":93959010,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"New Cohort Study Data Shows Baxter\u2019s Expanded Hemodialysis \u2013 Known as HDx Therapy \u2013 Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years","short_text":"\n\nFour-year study involved more than 1,000 dialysis patients from a large dialysis provider in Colombia Study compared Baxter\u2019s HDx therapy enabled by Theranova dialyzer with high-flux...","one_line_short_text":"\n\nFour-year study involved more than 1,000 dialysis patients from a large dialysis provider in Colombia Study compared Baxter\u2019s HDx therapy...","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/baxter-BAX\/stock-news\/93942394\/new-cohort-study-data-shows-baxter-s-expanded-hem","source":"Business Wire","source_logo":"\/common\/images\/news-sources\/bw.png","tags":[],"timestamp":1716986700,"date":"Wed May 29, 2024 ","time":"8:45 AM (2 months ago)","full_date":"May 29, 2024 8:45 AM","post_time":"May 29 2024","article_id":93942394,"source_id":"bw","media_url":null,"press_release":true},{"headline":"Baxter to Present at Jefferies 2024 Global Healthcare Conference","short_text":"\nBaxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies 2024 Global Healthcare Conference on Wednesday, June 5, 2024. Joel Grade, Baxter\u2019s chief financial...","one_line_short_text":"\nBaxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies 2024 Global Healthcare Conference on Wednesday, June...","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/baxter-BAX\/stock-news\/93917916\/baxter-to-present-at-jefferies-2024-global-healthc","source":"Business Wire","source_logo":"\/common\/images\/news-sources\/bw.png","tags":[],"timestamp":1716495300,"date":"Thu May 23, 2024 ","time":"4:15 PM (2 months ago)","full_date":"May 23, 2024 4:15 PM","post_time":"May 23 2024","article_id":93917916,"source_id":"bw","media_url":null,"press_release":true}],"All News": [{"headline":"Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project","link":"https:\/\/ih.advfn.com\/common\/newswire\/ct\/MjIxMA==","timestamp":1721905200,"date":"Thu Jul 25, 2024 ","time":"7:00 AM (4 hours ago)","isPromoted":true},{"headline":"Form 8-K - Current report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/baxter-BAX\/stock-news\/94218452\/form-8-k-current-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1721335565,"date":"Thu Jul 18, 2024 ","time":"4:46 PM (7 days ago)","full_date":"July 18, 2024 4:46 PM","post_time":"July 18 2024","article_id":94218452,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Baxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors","short_text":"\nBaxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2024 financial results on Tuesday, August 6, 2024 at 7:30 a.m. Central...","one_line_short_text":"\nBaxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2024 financial results...","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/baxter-BAX\/stock-news\/94210634\/baxter-to-host-second-quarter-2024-financial-resul","source":"Business Wire","source_logo":"\/common\/images\/news-sources\/bw.png","tags":[],"timestamp":1721247300,"date":"Wed Jul 17, 2024 ","time":"4:15 PM (1 week ago)","full_date":"July 17, 2024 4:15 PM","post_time":"July 17 2024","article_id":94210634,"source_id":"bw","media_url":null,"press_release":true},{"headline":"Baxter Declares Quarterly Dividend","short_text":"\nBaxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend...","one_line_short_text":"\nBaxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend...","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/baxter-BAX\/stock-news\/94203559\/baxter-declares-quarterly-dividend","source":"Business Wire","source_logo":"\/common\/images\/news-sources\/bw.png","tags":[],"timestamp":1721162700,"date":"Tue Jul 16, 2024 ","time":"4:45 PM (1 week ago)","full_date":"July 16, 2024 4:45 PM","post_time":"July 16 2024","article_id":94203559,"source_id":"bw","media_url":null,"press_release":true},{"headline":"Baxter publishes annual corporate responsibility report, highlighting continued focus on creating lasting impact","short_text":"\nProvides updates on Baxter\u2019s 2030 Corporate Responsibility Commitment and Goals and reinforces the company\u2019s commitment to transparent reporting Baxter International Inc. (NYSE:BAX), a global...","one_line_short_text":"\nProvides updates on Baxter\u2019s 2030 Corporate Responsibility Commitment and Goals and reinforces the company\u2019s commitment to transparent reporting...","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/baxter-BAX\/stock-news\/94172380\/baxter-publishes-annual-corporate-responsibility-r","source":"Business Wire","source_logo":"\/common\/images\/news-sources\/bw.png","tags":[],"timestamp":1720614600,"date":"Wed Jul 10, 2024 ","time":"8:30 AM (2 weeks ago)","full_date":"July 10, 2024 8:30 AM","post_time":"July 10 2024","article_id":94172380,"source_id":"bw","media_url":null,"press_release":true},{"headline":"Paramount-Skydance $28B Merger, Boeing Agrees to Plead Guilty with $243.6M Fine, and More News","short_text":"\nParamount Global (NASDAQ:PARA) – Skydance Media and Paramount Global announced a merger, with Skydance acquiring National Amusem*nts for $2.4 billion before merging with Paramount. This...","one_line_short_text":"\nParamount Global (NASDAQ:PARA) – Skydance Media and Paramount Global announced a merger, with Skydance acquiring National Amusem*nts for...","link":"https:\/\/ih.advfn.com\/market-news\/article\/7862\/paramount-skydance-28b-merger-boeing-agrees-to-plead-guilty-with-243-6m-fine-and-more-news","source":"IH Market News","source_logo":"\/common\/images\/news-sources\/ihmarketnews.png","tags":[],"timestamp":1720435072,"date":"Mon Jul 08, 2024 ","time":"6:37 AM (2 weeks ago)","full_date":"July 8, 2024 6:37 AM","post_time":"July 08 2024","article_id":94157279,"source_id":"ihmarketnews","media_url":null,"press_release":true},{"headline":"Baxter to Present at Goldman Sachs 45th Annual Global Healthcare Conference","short_text":"\nBaxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024. Joel Grade, Baxter\u2019s chief...","one_line_short_text":"\nBaxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Goldman Sachs 45th Annual Global Healthcare Conference on...","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/baxter-BAX\/stock-news\/94000922\/baxter-to-present-at-goldman-sachs-45th-annual-glo","source":"Business Wire","source_logo":"\/common\/images\/news-sources\/bw.png","tags":[],"timestamp":1717704900,"date":"Thu Jun 06, 2024 ","time":"4:15 PM (2 months ago)","full_date":"June 6, 2024 4:15 PM","post_time":"June 06 2024","article_id":94000922,"source_id":"bw","media_url":null,"press_release":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/baxter-BAX\/stock-news\/93993002\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1717617831,"date":"Wed Jun 05, 2024 ","time":"4:03 PM (2 months ago)","full_date":"June 5, 2024 4:03 PM","post_time":"June 05 2024","article_id":93993002,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form 4 - Statement of changes in beneficial ownership of securities","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/baxter-BAX\/stock-news\/93992999\/form-4-statement-of-changes-in-beneficial-owners","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1717617804,"date":"Wed Jun 05, 2024 ","time":"4:03 PM (2 months ago)","full_date":"June 5, 2024 4:03 PM","post_time":"June 05 2024","article_id":93992999,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"Form SD - Specialized disclosure report","short_text":"","one_line_short_text":"","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/baxter-BAX\/stock-news\/93959010\/form-sd-specialized-disclosure-report","source":"Edgar (US Regulatory)","source_logo":"\/common\/images\/news-sources\/edgar2.png","tags":["REGULATORY"],"timestamp":1717157444,"date":"Fri May 31, 2024 ","time":"8:10 AM (2 months ago)","full_date":"May 31, 2024 8:10 AM","post_time":"May 31 2024","article_id":93959010,"source_id":"edgar2","media_url":null,"press_release":true},{"headline":"New Cohort Study Data Shows Baxter\u2019s Expanded Hemodialysis \u2013 Known as HDx Therapy \u2013 Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years","short_text":"\n\nFour-year study involved more than 1,000 dialysis patients from a large dialysis provider in Colombia Study compared Baxter\u2019s HDx therapy enabled by Theranova dialyzer with high-flux...","one_line_short_text":"\n\nFour-year study involved more than 1,000 dialysis patients from a large dialysis provider in Colombia Study compared Baxter\u2019s HDx therapy...","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/baxter-BAX\/stock-news\/93942394\/new-cohort-study-data-shows-baxter-s-expanded-hem","source":"Business Wire","source_logo":"\/common\/images\/news-sources\/bw.png","tags":[],"timestamp":1716986700,"date":"Wed May 29, 2024 ","time":"8:45 AM (2 months ago)","full_date":"May 29, 2024 8:45 AM","post_time":"May 29 2024","article_id":93942394,"source_id":"bw","media_url":null,"press_release":true},{"headline":"Baxter to Present at Jefferies 2024 Global Healthcare Conference","short_text":"\nBaxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies 2024 Global Healthcare Conference on Wednesday, June 5, 2024. Joel Grade, Baxter\u2019s chief financial...","one_line_short_text":"\nBaxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies 2024 Global Healthcare Conference on Wednesday, June...","link":"https:\/\/ih.advfn.com\/stock-market\/NYSE\/baxter-BAX\/stock-news\/93917916\/baxter-to-present-at-jefferies-2024-global-healthc","source":"Business Wire","source_logo":"\/common\/images\/news-sources\/bw.png","tags":[],"timestamp":1716495300,"date":"Thu May 23, 2024 ","time":"4:15 PM (2 months ago)","full_date":"May 23, 2024 4:15 PM","post_time":"May 23 2024","article_id":93917916,"source_id":"bw","media_url":null,"press_release":true}],"Preferred Contributors": ""}},created: function () {this.loaded = true;Vue.nextTick(function(){});}});});
More Baxter International Inc News Articles
